NextCell Pharma AB's total assets for Q2 2025 were kr61.47M, a decrease of -11.31% from the previous quarter. SE:NXTCL total liabilities were kr10.11M for the fiscal quarter, a 3.70% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.